-
Patent Agency Ranking
公开(公告)号：KR1020120064299A
公开(公告)日：2012-06-19
申请号：KR1020100125468
申请日：2010-12-09
Applicant: (주)아모레퍼시픽
CPC classification number: A61K36/82 , A61K36/44 , A61K36/48 , A61K2236/19 , C12P1/04
Abstract: PURPOSE: A composition containing fermented tea extract is provided to reduce body fat and to prevent or treat obesity and cardiovascular diseases. CONSTITUTION: A composition for reducing body fat level contains fermented tea extract as an active ingredient which is prepared by inoculating strain to tea. A composition for suppressing lipid decomposition contains the fermented tea extract as an active ingredient. The tea includes green tea, white tea, oolong tea, pure tea, black tea, or persimmon leaf tea. The strain includes Bacillus subtilis, Bacillus licheniformis, Bacillus megateriums, Bacillus natto, Bacillus citreus, Bacillus circulans, Bacillus mesentricus, or Bacillus pumilus.
Abstract translation: 目的：提供含有发酵茶提取物的组合物，以减少体内脂肪，预防或治疗肥胖和心血管疾病。 构成：用于降低体脂肪含量的组合物含有作为活性成分的发酵茶提取物，其通过将菌株接种到茶中而制备。 用于抑制脂质分解的组合物含有发酵茶提取物作为活性成分。 茶包括绿茶，白茶，乌龙茶，纯茶，红茶或柿子茶。 该菌株包括枯草芽孢杆菌，地衣芽孢杆菌，巨大芽孢杆菌，纳豆芽孢杆菌，柠檬酸芽孢杆菌，环状芽孢杆菌，肠杆菌或短小芽孢杆菌。
-
公开(公告)号：KR101816638B1
公开(公告)日：2018-01-10
申请号：KR1020110099525
申请日：2011-09-30
Applicant: (주)아모레퍼시픽
IPC: A61K36/82 , A61K31/7016 , A61K31/7028 , A61K31/56
Abstract: 본발명은차나무뿌리유래사포닌을포함하는구강용조성물에관한것으로, 더욱상세하게는차나무뿌리에서추출한트리테르페노이드사포닌을포함함으로써치은염또는치주염과같은치주질환을효과적으로예방또는치료하고, 구취를억제또는개선할수 있는효능이우수한구강용조성물에관한것이다.
Abstract translation: 本发明涉及含有茶树根衍生的皂甙，更具体地，通过包括来自茶植物的根衍生的并有效预防或治疗牙周病，如牙龈炎或牙周炎，抑制口臭一个三萜皂甙口服组合物 或者在提高功效方面优异的口服组合物。
-
公开(公告)号：KR1020130035323A
公开(公告)日：2013-04-09
申请号：KR1020110099525
申请日：2011-09-30
Applicant: (주)아모레퍼시픽
IPC: A61K36/82 , A61K31/7016 , A61K31/7028 , A61K31/56
CPC classification number: A61K31/704 , A61K8/602 , A61K8/97 , A61K36/82 , A61Q11/00 , Y10S514/8995
Abstract: PURPOSE: An oral composition containing saponin extracted from the root of Camellia sinensis is provided to ensure anticancer effect, to prevent or treat periodontal diseases, and to suppress or treat halitosis. CONSTITUTION: An oral composition contains 0.01-65 wt% of saponin extracted from the root of Camellia sinensis. The saponin is triterpenoid saponin. Triterpenoid saponin prevents and treats periodontal diseases and suppresses halitosis. [Reference numerals] (AA) Oral physiotherapy index; (BB) Baseline; (CC) After 2 months; (DD) After 5 months; (EE) Comparative example 1; (FF) Example 1; (GG) Example 2;
Abstract translation: 目的：提供从山茶根提取的含有皂苷的口服组合物，以确保抗癌作用，预防或治疗牙周病，抑制或治疗口臭。 构成：口服组合物含有0.01-65重量％的从山茶根提取的皂苷。 皂苷是三萜皂苷。 三萜皂苷预防和治疗牙周病，抑制口臭。 （附图标记）（AA）口服理疗指标; （BB）基线; （CC）2个月后; （DD）5个月后; （EE）比较例1; （FF）实施例1; （GG）实施例2;
-
公开(公告)号：KR1020110110052A
公开(公告)日：2011-10-06
申请号：KR1020110029582
申请日：2011-03-31
Applicant: (주)아모레퍼시픽
Abstract: 본 발명은 쿠메스트롤; 또는 쿠메스트롤을 포함하는 콩 추출물을 포함하는 피부 미용용 조성물을 개시한다.
-
公开(公告)号：KR1020110079564A
公开(公告)日：2011-07-07
申请号：KR1020100139838
申请日：2010-12-31
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61P25/28 , A61P25/00
Abstract: PURPOSE: A composition containing ginseng fruit extract for mitochondria activation is provided to enhance enzyme activity and mitochondria DNA amount and to promote fatigue recovery. CONSTITUTION: A composition for mitochondria activation contains 10-90 weight% of ginseng fruit extract as an active ingredient. The composition is used for strengthening muscle. The composition is used for treating or preventing brain diseases, degenerative diseases, nervous diseases, heart diseases, liver diseases, and pancreatic diseases. The composition is a health food composition or pharmaceutical composition. The ginseng fruit extract is a pulp extract or pericarp extract.
Abstract translation: 目的：提供含有人参果实提取物用于线粒体活化的组合物，以增强酶活性和线粒体DNA量，促进疲劳恢复。 构成：用于线粒体活化的组合物含有10-90重量％的人参果实提取物作为活性成分。 该组合物用于加强肌肉。 该组合物用于治疗或预防脑疾病，退行性疾病，神经疾病，心脏病，肝脏疾病和胰腺疾病。 组合物是保健食品组合物或药物组合物。 人参果实提取物是纸浆提取物或果皮提取物。
-
-
-
-
Search Results
25
records
(took 0.027 seconds)
